1Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation, 2001, 104 : 2886-2891.
2Boos C J, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J, 2006;27:136-139.
3Thambidorai SK, Parakh K, Martin DO, et al. Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation. Am J Cardiol, 2004, 94:805 - 807.
4Lip GYH, Patel JV, Hughes E, et al. High-Sensitivity C-Reactive Protein and Soluble CD40 Ligand as Indices of Inflammation and Platelet Activation in 880 Patients frith Nonvalvular Atrial Fibrillation: Relationship to Stroke Risk Factors, Stroke Risk Stratification Schema, and Prognosis. Stroke, 2007, 38: 1229- 1237.
5Conway DS, Buggins P, Hughes E,et al Relation of interleukin- 6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation. Am J Cardiol, 2004,93:1368-1373.
6Conway DS, Buggins P, Hughes E, et al. Relationship of interleukin-6 and C-reactive protein to the p rothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol, 2004, 43 : 2075 - 2082.
7Anderson JL, Allen -Maycock CA, Lappe DL, et al. Frequency of elevation of C-reactive protein in atrial fibrillation Am J Cardiol, 2004,94:1255.
8Agarwal AK, Venugopalan P. Left atrial spontaneous echo contrast in patients with rheumatlcmitral valve stenosis in sinus rhythm: relationship to mitral valve and left atrial measurements. Int J Cardiol, 2001,77:63-68.
9Black IW. Spontaneous echo contrast: where there's smoke there' s fire. Echocardiography,2000,17:373-382.
10Roldan V, Marin F, Blann AD, et al. Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J, 2003, 24:1373 -1380.
